Efficacy and safety of ocrelizumab vs interferon beta-1a in participants of African descent with relapsing multiple sclerosis in the Phase III OPERA I and OPERA II studies

Title
Efficacy and safety of ocrelizumab vs interferon beta-1a in participants of African descent with relapsing multiple sclerosis in the Phase III OPERA I and OPERA II studies
Authors
Keywords
Interferon beta-1a, Ocrelizumab, Multiple sclerosis, African, Subgroup
Journal
Multiple Sclerosis and Related Disorders
Volume -, Issue -, Pages 103010
Publisher
Elsevier BV
Online
2021-05-08
DOI
10.1016/j.msard.2021.103010

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now